Authors: Ericsson, H Schwieler, J Lindmark, B Lofdahl, P Thulin, T Regardh, CG

Citation: H. Ericsson et al., Enantioselective pharmacokinetics of the enantiomers of clevidipine following intravenous infusion of the racemate in essential hypertensive patients, CHIRALITY, 13(3), 2001, pp. 130-134

Authors: Enstrom, I Burtscher, IM Eskilsson, J Holm, K Holtas, S Pennert, K Thulin, T

Citation: I. Enstrom et al., Organ damage in treated middle-aged hypertensives compared to normotensives: results from a cross-sectional study in general practice, BLOOD PRESS, 9(1), 2000, pp. 28-33

Authors: Boerma, M Forsberg, L Van Zeijl, L Morgenstern, R De Faire, U Lemne, C Erlinge, D Thulin, T Hong, Y Cotgreave, IA

Citation: M. Boerma et al., A genetic polymorphism in connexin 37 as a prognostic marker for atherosclerotic plaque development, J INTERN M, 246(2), 1999, pp. 211-218

Authors: Thulin, T Lehtonen, A Dahlof, C Nilsson-Ehle, P Engqvist, L Lagerstedt, C Berglund, E

Citation: T. Thulin et al., Long-term effects of diltiazem and atenolol on blood glucose, serum lipids, and serum urate in hypertensive patients, INT J CL PH, 37(1), 1999, pp. 28-33

Authors: Schwieler, JH Ericsson, H Lofdahl, P Thulin, T Kahan, T

Citation: Jh. Schwieler et al., Circulatory effects and pharmacology of clevidipine, a novel ultra short acting and vascular selective calcium antagonist, in hypertensive humans, J CARDIO PH, 34(2), 1999, pp. 268-274

Authors: Torffvit, O Agardh, CD Thulin, T

Citation: O. Torffvit et al., A study of Tamm-Horsfall protein excretion in hypertensive patients and type 1 diabetic patients, SC J UROL N, 33(3), 1999, pp. 187-191